Login
Signup
Uorane_tuga
@Uorane_tuga
1Semana
What made you buy this specific one tho?🧐
Me gusta
•
•
Respuesta
Jonas Hoffmann
@JonathanFrank
1Semana
@Uorane_tuga
- Reasonable P/E ~19
- EPS rising + buybacks = negative dilution
- Revenue climbing, with upside from oncology pipeline (colorectal, kidney, solid tumors)
- US-based → less regulation hassle
Others may fit, but this one ticks all my boxes.
Me gusta
•
👍
1
1
•
Respuesta